Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 36, Issue 3, 2013, Pages 545-553

  Iuliano, Luigi ^a   Pacelli, Antonio ^a   Ciacciarelli, Marco ^a   Zerbinati, Chiara ^a   Fagioli, Sabrina ^b   Piras, Fabrizio ^b   Orfei, Maria Donata ^b   Bossù, Paola ^b   Pazzelli, Floriana ^a,b   Serviddio, Gaetano ^d   Caltagirone, Carlo ^b,c   Spalletta, Gianfranco ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Alzheimer's disease; fatty acids; linoleic acid; neurodegeneration

Indexed keywords

15 TETRACOSENOIC ACID; 5,8,11 ICOSATRIENOIC ACID; ADRENIC ACID; ARACHIDIC ACID; ARACHIDONIC ACID; BEHENIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSADIENOIC ACID; ELAIDIC ACID; ERUCIC ACID; GAMMA LINOLENIC ACID; GONDOLIC ACID; HEXACOSANOIC ACID; ICOSATRIENOIC ACID; LIGNOCERIC ACID; LINOLEIC ACID; LINOLENIC ACID; MONOUNSATURATED FATTY ACID; MYRISTIC ACID; MYRISTOLEIC ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OSBOND ACID; PALMITIC ACID; PALMITOLEIC ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STEARIC ACID; TRANS FATTY ACID; UNCLASSIFIED DRUG; VACCENIC ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR CHANGE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; DISEASE COURSE; FATTY ACID BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; LIPIDOMICS; LOCOMOTION; MALE; MILD COGNITIVE IMPAIRMENT; NERVE DEGENERATION; NEUROIMAGING; PRIORITY JOURNAL;

EID: 84881402835     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122224     Document Type: Article

References (46)

1. Morris MC, EvansDA, Bienias JL, Tangney CC, BennettDA, Wilson RS, Aggarwal N, Schneider J (2003) Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 60, 940-946
2. Barberger-Gateau P, Letenneur L, Deschamps V, Ṕerès K, Dartigues JF, Renaud S (2002) Fish, meat, and risk of dementia: Cohort study. BMJ 325, 932-933
3. Cunnane SC, Plourde M, Pifferi F, Begin M, Feart C, Barberger-Gateau P (2009) Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 48, 239-256
4. Gu Y, Schupf N, Cosentino SA, Luchsinger JA, Scarmeas N (2012) Nutrient intake and plasma β-Amyloid. Neurology 78, 1832-1840
5. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR, Jr., Weiner M, Shinto L, Aisen PS (2010) Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. JAMA 304, 1903-1911
6. Fotuhi M, Mohassel P, Yaffe K (2009) Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: A complex association. Nat Clin Pract Neurol 5, 140-152
7. Kroger E, Verreault R, Carmichael PH, Lindsay J, Julien P, Dewailly E, Ayotte P, Laurin D (2009) Omega-3 fatty acids and risk of dementia: The Canadian Study of Health and Aging. Am J Clin Nutr 90, 184-192
8. Geleijnse JM, Giltay EJ, Kromhout D (2012) Effects of n-3 fatty acids on cognitive decline: A randomized, doubleblind, placebo-controlled trial in stable myocardial infarction patients. Alzheimers Dement 8, 278-287
9. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS (2008) Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134, 933-944
10. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308
11. Morris JC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43, 2412-2414
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944
13. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198
14. Carlesimo GA, Caltagirone C, Gainotti G (1996) The Mental Deterioration Battery: Normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 36, 378-384
15. Rey A (1941) L'examen psychologique dan les cas d'encephalopathie traumatique (lès problemes). Arch Psychol 28, 286-340
16. Osterrieth P (1944) Le test de copie d'une figure complexe. Arch Psychol 30, 206-356
17. Stroop J (1935) Studies of interference in serial verbal reactions. J Experim Psycol 18, 643-662
18. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 44, 2308-2314
19. Lepage G, Roy CC (1986) Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27, 114-120
20. Masood A, Stark KD, Salem N, Jr. (2005) A simplified and efficient method for the analysis of fatty acid methyl esters suitable for large clinical studies. J Lipid Res 46, 2299-2305
21. Iuliano L, Monticolo R, Straface G, Zullo S, Galli F, Boaz M, Quattrucci S (2009) Association of cholesterol oxidation and abnormalities in fatty acid metabolism in cystic fibrosis. Am J Clin Nutr 90, 477-484
22. Lizard G, Rouaud O, Demarquoy J, Cherkaoui-Malki M, Iuliano L (2012) Potential roles of peroxisomes in Alzheimer's disease and in dementia of the Alzheimer's type. J Alzheimers Dis 29, 241-254
23. Luchsinger JA, Mayeux R (2004) Dietary factors and Alzheimer's disease. Lancet Neurol 3, 579-587
24. Engelhart MJ, Geerlings MI, Ruitenberg A, Van Swieten JC, Hofman A,Witteman JC, BretelerMM(2002) Diet and risk of dementia: Does fat matter?: The Rotterdam Study. Neurology 59, 1915-1921
25. Morris MC (2009) The role of nutrition in Alzheimer's disease: Epidemiological evidence. Eur J Neurol 16(Suppl 1), 1-7
26. Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS (2004) Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology 62, 1573-1579
27. Oksman M, Iivonen H, Hogyes E, Amtul Z, Penke B, Leenders I, Broersen L, Lutjohann D, Hartmann T, TanilaH(2006) Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on β-Amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis 23, 563-572
28. Sparks DL, Scheff SW, Hunsaker JC, 3rd, Liu H, Landers T, Gross DR (1994) Induction of Alzheimer-like β-Amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 126, 88-94
29. Wilson DM, Binder LI (1997) Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am J Pathol 150, 2181-2195
30. Patil S, Sheng L, Masserang A, Chan C (2006) Palmitic acid-treated astrocytes induce BACE1 upregulation and accumulation of C-terminal fragment of APP in primary cortical neurons. Neurosci Lett 406, 55-59
31. Siguel EN, Chee KM, Gong JX, Schaefer EJ (1987) Criteria for essential fatty acid deficiency in plasma as assessed by capillary column gas-liquid chromatography. Clin Chem 33, 1869-1873
32. Cunnane SC, Schneider JA, Tangney C, Tremblay-Mercier J, Fortier M, Bennett DA, Morris MC (2012) Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 29, 691-697
33. Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR (2007) Plasma n-3 fatty acids and the risk of cognitive decline in older adults: The Atherosclerosis Risk in Communities Study. Am J Clin Nutr 85, 1103-1111
34. Iso H, Sato S, Umemura U, Kudo M, Koike K, Kitamura A, Imano H, Okamura T, Naito Y, Shimamoto T (2002) Linoleic acid, other fatty acids, and the risk of stroke. Stroke 33, 2086-2093
35. Wang Z-J, Liang C-L, Li G-M, Yu C-Y, YinM(2006) Neuroprotective effects of arachidonic acid against oxidative stress on rat hippocampal slices. Chem Biol Interact 163, 207-217
36. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Schneider J,Wilson RS (2003) Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 60, 194-200
37. Taha A, Filo E, Ma D, McIntyre Burnham W (2009) Dose-dependent anticonvulsant effects of linoleic and alphalinolenic polyunsaturated fatty acids on pentylenetetrazol induced seizures in rats. Epilepsia 50, 72-82
38. Hammarstrom S (1981) Conversion of 5,8,11-eicosatrienoic acid to leukotrienes C3 and D3. J Biol Chem 256, 2275-2279
39. Wei YF, Evans RW, Morrison AR, Sprechert H, Jakschik BA (1985) Double bond requirement for the 5-lipoxygenase pathway. Prostaglandins 29, 537-545
40. Patel P, Cossette C, Anumolu JR, Gravel S, Lesimple A, Mamer OA, Rokach J, Powell WS (2008) Structural requirements for activation of the 5-oxo-6E,8Z, 11Z,14Zeicosatetraenoic acid (5-oxo-ETE) receptor: Identification of a mead acid metabolite with potent agonist activity. J Pharmacol Exp Ther 325, 698-707
41. De CaterinaR(2011) n-3 fatty acids in cardiovascular disease. N Engl J Med 364, 2439-2450
42. Lim WS, Gammack JK, Van Niekerk J, Dangour AD (2006) Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst Rev, CD005379
43. Iuliano L, Palmaccio G, Bottaccioli A, Zerbinati C (2012) N3 fatty acids and neurodegeneration: Is it enough to stop or to shift? J Alzheimers Dis Parkinsonism 2, e119
44. Amtul Z, Uhrig M, Beyreuther K (2011) Additive effects of fatty acid mixtures on the levels and ratio of amyloid β40/42 peptides differ from the effects of individual fatty acids. J Neurosci Res 89, 1795-1801
45. Bernoud-Hubac N, Davies SS, Boutaud O, Montine TJ, Roberts LJ, 2nd (2001) Formation of highly reactive gammaketoaldehydes (neuroketals) as products of the neuroprostane pathway. J Biol Chem 276, 30964-30970
46. Fam S, Murphey L, Terry E, Zackert W, Chen Y, Gao L, Pandalai S, Milne G, Roberts L, Porter N (2002) Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 277, 36076-36084